Swedbank AB Increases Stock Holdings in UnitedHealth Group Incorporated $UNH

Key Points

• Swedbank AB increased its stake in UnitedHealth Group (UNH) by 0.7% in Q4, buying 8,191 shares to hold 1,121,006 shares worth about $370,055,000 (roughly 0.12% of the company).
• UNH beat Q1 expectations with $7.23 EPS (vs. $6.76 consensus), raised FY‑2026 guidance to about $18.25 EPS, and has seen positive signals from analysts and actions like increased share buybacks and inclusion on Goldman Sachs' Conviction List.
• Management plans to remove prior‑authorization requirements for roughly 30% of services, which could cut administrative costs but also boost utilization and near‑term medical claims—analysts caution Q2 will be a clearer test of medical‑cost trends.

Swedbank AB boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 0.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,121,006 shares of the healthcare conglomerate's stock after acquiring an additional 8,191 shares during the quarter. Swedbank AB owned 0.12% of UnitedHealth Group worth $370,055,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the stock. Vanguard Group Inc. increased its stake in UnitedHealth Group by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 91,600,260 shares of the healthcare conglomerate's stock valued at $30,238,162,000 after purchasing an additional 995,210 shares during the last quarter. Capital World Investors boosted its stake in shares of UnitedHealth Group by 18.8% in the third quarter. Capital World Investors now owns 21,766,922 shares of the healthcare conglomerate's stock valued at $7,516,107,000 after buying an additional 3,439,182 shares in the last quarter. Capital International Investors raised its holdings in UnitedHealth Group by 11.1% during the third quarter. Capital International Investors now owns 17,499,949 shares of the healthcare conglomerate's stock worth $6,042,710,000 after purchasing an additional 1,747,337 shares during the last quarter. Capital Research Global Investors raised its holdings in shares of UnitedHealth Group by 126.9% in the third quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate's stock worth $4,503,419,000 after acquiring an additional 7,293,009 shares during the last quarter. Finally, Dodge & Cox raised its holdings in shares of UnitedHealth Group by 8.6% in the third quarter. Dodge & Cox now owns 9,505,636 shares of the healthcare conglomerate's stock worth $3,282,296,000 after acquiring an additional 755,076 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealthcare will eliminate prior-authorization requirements for roughly 30% of services, aiming to cut administrative cost/complexity and speed care for members — a move investors view as operationally constructive. UnitedHealthcare removes prior approval requirements for 30% of healthcare services
• Positive Sentiment: UnitedHealth reported a Q1 earnings beat and raised 2026 guidance, which investors credited for improved profitability and helped lift sentiment. Why UnitedHealth Group Stock Came Roaring Back In April
• Positive Sentiment: Goldman Sachs added UNH to its U.S. Conviction List and maintained a $435 price target, signaling confidence in the company’s recovery in Medicare underwriting. Goldman Sachs Names UnitedHealth to Conviction List
• Positive Sentiment: Management is boosting share buybacks, which markets interpret as a signal that leadership views the stock as undervalued and supports EPS. According to These Metrics, UnitedHealth Stock Looks Undervalued
• Neutral Sentiment: Analysts warn first-quarter results mask a lag in claims; Q2 will be a clearer test of medical-cost trends, so investors should monitor claims development closely. Major health insurers show signs of recovery – but a key test looms
• Negative Sentiment: Removing prior authorizations could also lift utilization and near-term medical costs; investors should weigh potential savings from lower admin burden against higher claims risk. UnitedHealth to drop preapproval requirements for some services
• Negative Sentiment: A shareholder proposal seeking an independent board chair and recent executive moves (e.g., a UNH leader joining Highmark) add governance and talent-transition angles investors may watch. How Investors Are Reacting To UnitedHealth Group Earnings Beat, Guidance Hike and Governance Challenge

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the company's stock in a transaction that occurred on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the sale, the chief executive officer owned 17,805 shares in the company, valued at $6,320,775. This represents a 4.30% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 0.28% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of analyst reports. Piper Sandler reissued an "overweight" rating on shares of UnitedHealth Group in a report on Tuesday, January 27th. UBS Group cut their price target on UnitedHealth Group from $430.00 to $410.00 and set a "buy" rating for the company in a report on Wednesday, January 28th. TD Cowen boosted their price target on UnitedHealth Group from $311.00 to $337.00 and gave the stock a "hold" rating in a report on Thursday, April 23rd. HSBC raised UnitedHealth Group from a "reduce" rating to a "hold" rating and set a $300.00 price target for the company in a research report on Tuesday, April 7th. Finally, Royal Bank Of Canada increased their price target on UnitedHealth Group from $361.00 to $400.00 and gave the company an "outperform" rating in a report on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, twenty have assigned a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and an average price target of $378.88.

UnitedHealth Group Trading Down 1.9%

Shares of UNH opened at $363.83 on Wednesday. The company has a market capitalization of $330.43 billion, a P/E ratio of 27.48, a P/E/G ratio of 1.60 and a beta of 0.64. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $404.72. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.80. The stock has a 50-day moving average price of $300.93 and a 200 day moving average price of $316.81.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, beating analysts' consensus estimates of $6.76 by $0.47. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The firm had revenue of $111.65 billion during the quarter, compared to the consensus estimate of $109.84 billion. During the same quarter in the prior year, the business posted $7.20 earnings per share. UnitedHealth Group's revenue for the quarter was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 18.29 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were paid a dividend of $2.21 per share. The ex-dividend date was Monday, March 9th. This represents a $8.84 annualized dividend and a yield of 2.4%. UnitedHealth Group's dividend payout ratio is presently 66.77%.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.